Cash flow NEC Corporation

Equities

6701

JP3733000008

IT Services & Consulting

Market Closed - Japan Exchange Other stock markets 07:30:00 10/04/2026 BST			5-day change	1st Jan Change
3,860.00 ^JPY	-4.64%		-4.60%	-27.31%

04-03	Transgene, NEC Bio Enter Partnership to Develop Cancer Vaccine	MT
04-02	Transgene and NEC Bio Sign License Agreement for TG4050 Development in Head and Neck Cancer	CI

4a.oVnePnwnsOjYeb_wA39DBERe4V7lQg_P_v5AmnTX1U0.1jW1fwxjyoehKcyJNy8NaCZn1my6Gmmem4wE2TOAuw7uKJIHFFXCt4cr_g

Published financial data: NEC CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	2,994B	3,014B	3,313B	3,477B	3,423B
Total Revenues	2,994B	3,014B	3,313B	3,477B	3,423B
Cost of Goods Sold, Total	2,133B	2,128B	2,355B	2,471B	2,363B
Gross Profit	861B	886B	958B	1,006B	1,061B
Selling General & Admin Expenses, Total	732B	763B	794B	814B	777B
R&D Expenses	-	-	-	-	-
Other Operating Expenses	-25.56B	-9.08B	-5.9B	3.83B	26.64B
Other Operating Expenses, Total	706B	754B	788B	818B	804B
Operating Income	155B	133B	170B	188B	256B
Interest Expense, Total	-10.61B	-8.03B	-8B	-12.15B	-9.46B
Interest And Investment Income	9.69B	5.81B	6.98B	8.92B	9.64B
Net Interest Expenses	-922M	-2.23B	-1.02B	-3.23B	176M
Income (Loss) On Equity Invest.	4.99B	5.38B	3.95B	5.27B	-10.1B
Currency Exchange Gains (Loss)	-	2.02B	-4.16B	-2.6B	-2.86B
Other Non Operating Income (Expenses)	-	-3B	2.18B	-2.44B	-3.94B
EBT, Excl. Unusual Items	159B	135B	171B	185B	240B
Restructuring Charges	-	-	-	-	-
Merger & Related Restructuring Charges	-1.3B	-	-	-	-
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Investments	-	9.74B	-3.73B	-	-
Gain (Loss) On Sale Of Assets	-	-	-	-	-
Asset Writedown	-	-	-	-	-
Insurance Settlements	-	-	-	-	-
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	158B	144B	168B	185B	240B
Income Tax Expense	-4.04B	-12.27B	36.16B	20.26B	55.11B
Earnings From Continuing Operations	162B	157B	132B	165B	185B
Net Income to Company	162B	157B	132B	165B	185B
Minority Interest	-12.26B	-15.43B	-17.02B	-15.23B	-9.48B
Net Income - (IS)	150B	141B	114B	150B	175B
Net Income to Common Incl Extra Items	150B	141B	114B	150B	175B
Net Income to Common Excl. Extra Items	150B	141B	114B	150B	175B
Per Share Items
Net EPS - Basic	111.44	103.71	84.9	112.25	131.5
Basic EPS - Continuing Operations	111.44	103.71	84.9	112.25	131.5
Basic Weighted Average Shares Outstanding	1.34B	1.36B	1.35B	1.33B	1.33B
Net EPS - Diluted	111.44	103.71	84.9	112.25	131.49
Diluted EPS - Continuing Operations	111.44	103.71	84.9	112.25	131.49
Diluted Weighted Average Shares Outstanding	1.34B	1.36B	1.35B	1.33B	1.33B
Normalized Basic EPS	64.95	50.48	66.82	75.37	105.37
Normalized Diluted EPS	64.95	50.48	66.82	75.37	105.37
Dividend Per Share	18	20	22	24	28
Payout Ratio	14.23	19.29	24.91	20.5	19.8
American Depositary Receipts Ratio (ADR)	0.5	0.5	0.5	0.5	0.5
Supplemental Items
EBITDA	323B	313B	354B	376B	415B
EBITA	155B	133B	170B	188B	256B
EBIT	155B	133B	170B	188B	256B
EBITDAR	-	-	-	-	-
Effective Tax Rate - (Ratio)	-2.56	-8.49	21.56	10.95	22.98
Total Current Taxes	-	-	-	-	-
Total Deferred Taxes	-	-	-	-	-
Normalized Net Income	87.2B	68.76B	90.11B	100B	140B
Non-Cash Pension Expense	-	558M	-44M	598M	-2.65B
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	-	126B	121B	116B	99.19B
Net Rental Expense, Total	-	-	-	-	-
Imputed Operating Lease Interest Expense	-	-	-	-	-
Imputed Operating Lease Depreciation	-	-	-	-	-
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	-	-	-	-	-

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	523B	431B	419B	476B	585B
Short Term Investments	9.57B	-	-	-	-
Total Cash And Short Term Investments	533B	431B	419B	476B	585B
Accounts Receivable, Total	1,011B	722B	800B	829B	878B
Other Receivables	-	-	-	-	-
Total Receivables	1,011B	722B	800B	829B	878B
Inventory	186B	246B	268B	243B	185B
Prepaid Expenses	-	59.66B	66.57B	68.67B	78.52B
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	132B	378B	442B	524B	499B
Total Current Assets	1,861B	1,837B	1,996B	2,142B	2,225B
Gross Property Plant And Equipment	1,523B	-	-	-	-
Accumulated Depreciation	-970B	-	-	-	-
Net Property Plant And Equipment	553B	540B	563B	511B	580B
Long-term Investments	284B	521B	531B	654B	587B
Goodwill	301B	336B	356B	392B	394B
Other Intangibles, Total	369B	375B	378B	372B	352B
Loans Receivable Long-Term	-	-	-	-	-
Deferred Tax Assets Long-Term	134B	153B	160B	157B	177B
Deferred Charges Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	168B	-	-	-	-
Total Assets	3,669B	3,762B	3,984B	4,228B	4,315B
Liabilities
Accounts Payable, Total	468B	447B	498B	520B	493B
Accrued Expenses, Total	216B	232B	241B	253B	250B
Short-term Borrowings	-	82.24B	44.17B	24.59B	159B
Current Portion of Long-Term Debt	51.51B	105B	86.7B	60.07B	74.53B
Current Portion of Leases	47.48B	49.46B	47.06B	52.58B	52.52B
Current Income Taxes Payable	28.15B	54.73B	63.75B	76.11B	114B
Unearned Revenue Current, Total	250B	-	-	-	-
Other Current Liabilities	137B	364B	385B	484B	484B
Total Current Liabilities	1,198B	1,334B	1,366B	1,469B	1,627B
Long-Term Debt	489B	258B	321B	298B	256B
Long-Term Leases	115B	103B	110B	113B	124B
Pension & Other Post Retirement Benefits	192B	180B	179B	158B	138B
Deferred Tax Liability Non Current	-	44.78B	44.62B	37.14B	32.12B
Other Non Current Liabilities	113B	55.59B	51.53B	62.45B	66.98B
Total Liabilities	2,107B	1,975B	2,071B	2,138B	2,244B
Common Stock, Total	428B	428B	428B	428B	428B
Additional Paid In Capital	169B	169B	165B	167B	46.7B
Retained Earnings	565B	679B	765B	883B	1,024B
Treasury Stock	-1.58B	-1.91B	-31.59B	-31.1B	-30.72B
Comprehensive Income and Other	148B	240B	298B	468B	484B
Total Common Equity	1,308B	1,514B	1,624B	1,916B	1,952B
Minority Interest	254B	273B	289B	174B	119B
Total Equity	1,562B	1,787B	1,913B	2,090B	2,072B
Total Liabilities And Equity	3,669B	3,762B	3,984B	4,228B	4,315B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	1.36B	1.36B	1.33B	1.33B	1.33B
ECS Total Common Shares Outstanding	1.36B	1.36B	1.33B	1.33B	1.33B
Book Value / Share	960.13	1.11K	1.22K	1.44K	1.46K
Tangible Book Value	639B	803B	890B	1,152B	1,206B
Tangible Book Value Per Share	468.83	589.32	668.29	864.36	905.11
Total Debt	703B	597B	608B	549B	666B
Net Debt	170B	167B	189B	72.15B	81.74B
Debt Equivalent of Unfunded Proj. Benefit Obligation	-	18.35B	-15.3B	-133B	-89.23B
Debt Equivalent Oper. Leases	-	-	-	-	-
Minority Interest, Total (Incl. Fin. Div)	254B	273B	289B	174B	119B
Equity Method Investments, Total	73.32B	76.47B	80.42B	108B	107B
Account Code - Inventory Valuation	8	-	-	-	-
Inventories - Raw Materials, Total	-	86.78B	95.46B	79.78B	61.49B
Inventories - Work In Process, Total	-	75.74B	83.02B	65.24B	58.38B
Inventories - Finished Goods, Total	-	83.72B	89.1B	97.62B	64.91B
Land - (BS)	-	-	-	-	-
Buildings, Total	-	-	-	-	-
Machinery, Total	-	-	-	-	-
Full Time Employees	115K	117K	119K	105K	104K
Part Time Employees	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	5.8B	-	-	-	-

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	150B	144B	168B	185B	240B
Depreciation & Amortization - CF	168B	181B	183B	188B	158B
Amortization of Goodwill and Intangible Assets - (CF)	-	-	-	-	-
Depreciation & Amortization, Total	168B	181B	183B	188B	158B
Amortization of Deferred Charges, Total - (CF)	-	-	-	-	-
(Gain) Loss From Sale Of Asset	-	985M	6.86B	4.74B	9.59B
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-
Asset Writedown & Restructuring Costs	4.04B	-	-	-	-
(Income) Loss On Equity Investments - (CF)	-4.99B	-5.38B	-3.95B	-5.27B	10.1B
Other Operating Activities, Total	-74.16B	-49.12B	-31.36B	-46.23B	-40.25B
Change In Accounts Receivable	-16.02B	25.47B	-77.3B	-64.75B	-55.8B
Change In Inventories	19.25B	-58.85B	-23.43B	-6.66B	52.73B
Change In Accounts Payable	4.93B	-27.43B	41.11B	24.22B	-12.58B
Change in Unearned Revenues	24.65B	-	-	-	-
Change in Other Net Operating Assets	-	-63.12B	-111B	-7.53B	-17.6B
Cash from Operations	275B	148B	152B	271B	344B
Capital Expenditure	-59.31B	-56.95B	-56.39B	-75.18B	-126B
Sale of Property, Plant, and Equipment	41.76B	15.37B	12.39B	7.66B	8.7B
Cash Acquisitions	-203B	-12.35B	-7.13B	-1.09B	-6.67B
Divestitures	5.58B	7.18B	11.63B	-6.89B	15.38B
Sale (Purchase) of Intangible assets	-11.63B	-14.16B	-21.32B	-24.59B	-24.22B
Investment in Marketable and Equity Securities, Total	103B	6.76B	17.09B	16.31B	1.59B
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	-	-	-
Other Investing Activities, Total	992M	-9.24B	-5.85B	7.76B	459M
Cash from Investing	-122B	-63.38B	-49.59B	-76.02B	-131B
Short Term Debt Issued, Total	-	38.7B	-	-	134B
Long-Term Debt Issued, Total	134B	382M	150B	40B	31.96B
Total Debt Issued	134B	39.08B	150B	40B	166B
Short Term Debt Repaid, Total	-47.33B	-	-39.98B	-21.34B	-
Long-Term Debt Repaid, Total	-157B	-138B	-105B	-86.7B	-61.23B
Total Debt Repaid	-204B	-138B	-145B	-108B	-61.23B
Issuance of Common Stock	64.13B	243M	865M	567M	470M
Repurchase of Common Stock	-	-	-30.55B	-74M	-
Common Dividends Paid	-21.3B	-27.26B	-28.52B	-30.66B	-34.68B
Common & Preferred Stock Dividends Paid	-21.3B	-27.26B	-28.52B	-30.66B	-34.68B
Other Financing Activities, Total	28.25B	-64.03B	-70.05B	-57.3B	-175B
Cash from Financing	1.39B	-190B	-123B	-156B	-104B
Foreign Exchange Rate Adjustments	6.12B	12.91B	8.93B	17.32B	-1.14B
Miscellaneous Cash Flow Adjustments	4.16B	-	-	-	-
Net Change in Cash	164B	-92.57B	-11.32B	57.03B	108B
Supplemental Items
Cash Interest Paid	7.81B	8.51B	7.42B	10.98B	9.1B
Cash Income Tax Paid (Refund)	24.46B	39.96B	37.41B	52.75B	47.11B
Levered Free Cash Flow	272B	108B	126B	254B	195B
Unlevered Free Cash Flow	278B	113B	131B	261B	201B
Change In Net Working Capital	-84.91B	78.78B	80.69B	-55.67B	-33.29B
Net Debt Issued / Repaid	-69.69B	-98.57B	5.47B	-68.04B	105B

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	2.85	2.23	2.75	2.86	3.75
Return on Total Capital	4.78	3.56	4.34	4.56	5.96
Return On Equity %	12.1	9.36	7.11	8.23	8.88
Return on Common Equity	13.49	10.01	7.3	8.45	9.06
Margin Analysis
Gross Profit Margin %	28.76	29.41	28.92	28.93	30.98
SG&A Margin	24.44	25.31	23.96	23.41	22.71
EBITDA Margin %	10.78	10.39	10.68	10.8	12.12
EBITA Margin %	5.18	4.4	5.14	5.41	7.49
EBIT Margin %	5.18	4.4	5.14	5.41	7.49
Income From Continuing Operations Margin %	5.41	5.2	3.97	4.74	5.39
Net Income Margin %	5	4.69	3.46	4.3	5.12
Net Avail. For Common Margin %	5	4.69	3.46	4.3	5.12
Normalized Net Income Margin	2.91	2.28	2.72	2.89	4.1
Levered Free Cash Flow Margin	9.08	3.6	3.82	7.29	5.71
Unlevered Free Cash Flow Margin	9.3	3.76	3.97	7.51	5.88
Asset Turnover
Asset Turnover	0.88	0.81	0.86	0.85	0.8
Fixed Assets Turnover	5.39	5.51	6	6.47	6.27
Receivables Turnover (Average Receivables)	3.06	3.55	4.35	4.27	4.01
Inventory Turnover (Average Inventory)	11.08	9.86	9.17	9.69	11.06
Short Term Liquidity
Current Ratio	1.55	1.38	1.46	1.46	1.37
Quick Ratio	1.29	0.86	0.89	0.89	0.9
Operating Cash Flow to Current Liabilities	0.23	0.11	0.11	0.18	0.21
Days Sales Outstanding (Average Receivables)	119.16	102.82	83.85	85.75	91.05
Days Outstanding Inventory (Average Inventory)	32.93	37.04	39.82	37.78	33.01
Average Days Payable Outstanding	75.04	72.22	72.54	76.1	80.17
Cash Conversion Cycle (Average Days)	77.05	67.63	51.14	47.43	43.89
Long Term Solvency
Total Debt/Equity	45	33.44	31.81	26.26	32.17
Total Debt / Total Capital	31.04	25.06	24.13	20.8	24.34
LT Debt/Equity	38.66	20.21	22.51	19.69	18.34
Long-Term Debt / Total Capital	26.66	15.15	17.08	15.59	13.88
Total Liabilities / Total Assets	57.43	52.5	51.99	50.57	52
EBIT / Interest Expense	14.61	16.5	21.3	15.47	27.1
EBITDA / Interest Expense	30.4	38.98	44.21	30.92	43.84
(EBITDA - Capex) / Interest Expense	24.82	31.89	37.16	24.73	30.49
Total Debt / EBITDA	2.18	1.91	1.72	1.46	1.61
Net Debt / EBITDA	0.53	0.53	0.53	0.19	0.2
Total Debt / (EBITDA - Capex)	2.67	2.33	2.05	1.83	2.31
Net Debt / (EBITDA - Capex)	0.65	0.65	0.64	0.24	0.28
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-3.27	0.67	9.92	4.96	-1.55
Gross Profit, 1 Yr. Growth %	-2.97	2.93	8.1	4.97	5.44
EBITDA, 1 Yr. Growth %	66.81	64.88	12.99	6.21	10.44
EBITA, 1 Yr. Growth %	5.75	-9.84	28.61	10.31	36.43
EBIT, 1 Yr. Growth %	16.97	2.35	28.61	10.31	36.43
Earnings From Cont. Operations, 1 Yr. Growth %	43.6	-3.19	-16.07	25.27	12.09
Net Income, 1 Yr. Growth %	49.66	-5.57	-18.95	30.59	17.16
Normalized Net Income, 1 Yr. Growth %	28.72	-0.5	31.05	11.42	39.82
Diluted EPS Before Extra, 1 Yr. Growth %	44.72	-6.94	-18.13	32.21	17.14
Accounts Receivable, 1 Yr. Growth %	7.07	-25.98	10.73	3.7	5.9
Inventory, 1 Yr. Growth %	-6.91	32.71	8.66	-9.32	-23.84
Net Property, Plant and Equip., 1 Yr. Growth %	-0.88	-2.33	4.28	-9.3	13.54
Total Assets, 1 Yr. Growth %	17.46	2.54	5.91	6.11	2.08
Tangible Book Value, 1 Yr. Growth %	16.06	22.17	10.86	29.39	4.75
Common Equity, 1 Yr. Growth %	43.65	15.7	7.29	17.97	1.9
Cash From Operations, 1 Yr. Growth %	4.98	-46.34	3.12	78.29	26.98
Capital Expenditures, 1 Yr. Growth %	-18.56	-3.98	-0.98	33.31	68.15
Levered Free Cash Flow, 1 Yr. Growth %	39.81	-57.86	16.56	100.53	-22.89
Unlevered Free Cash Flow, 1 Yr. Growth %	38.83	-56.8	15.81	98.68	-22.86
Dividend Per Share, 1 Yr. Growth %	28.57	11.11	10	9.09	16.67
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	1.37	-1.32	5.19	7.41	1.65
Gross Profit, 2 Yr. CAGR %	1.87	-0.06	5.49	6.52	5.2
EBITDA, 2 Yr. CAGR %	49.52	27.8	36.49	9.55	8.3
EBITA, 2 Yr. CAGR %	25.25	-4.36	7.69	19.11	22.67
EBIT, 2 Yr. CAGR %	30.06	0.66	14.74	19.11	22.67
Earnings From Cont. Operations, 2 Yr. CAGR %	76.55	17.91	-9.86	2.54	18.5
Net Income, 2 Yr. CAGR %	94.19	18.88	-12.52	2.88	23.69
Normalized Net Income, 2 Yr. CAGR %	32.91	1.58	14.19	20.84	24.81
Diluted EPS Before Extra, 2 Yr. CAGR %	90.99	16.05	-12.71	4.04	24.45
Accounts Receivable, 2 Yr. CAGR %	3.01	-12.53	-9.46	7.16	4.8
Inventory, 2 Yr. CAGR %	-11.07	11.15	20.09	-0.74	-16.9
Net Property, Plant and Equip., 2 Yr. CAGR %	16.32	-1.61	0.92	-2.75	1.48
Total Assets, 2 Yr. CAGR %	11.27	9.75	4.21	6.01	4.08
Tangible Book Value, 2 Yr. CAGR %	15.65	20.78	16.38	19.77	16.42
Common Equity, 2 Yr. CAGR %	23.41	28.92	11.41	12.5	9.64
Cash From Operations, 2 Yr. CAGR %	106.87	-24.94	-25.61	35.6	50.46
Capital Expenditures, 2 Yr. CAGR %	10.1	-11.57	-2.49	14.89	49.72
Levered Free Cash Flow, 2 Yr. CAGR %	63.13	-25.11	-29.91	52.89	24.35
Unlevered Free Cash Flow, 2 Yr. CAGR %	61.74	-24.58	-29.27	51.69	23.8
Dividend Per Share, 2 Yr. CAGR %	50	19.52	10.55	9.54	12.82
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	1.72	1.14	2.29	5.11	4.34
Gross Profit, 3 Yr. CAGR %	2.59	2.22	2.59	5.31	6.16
EBITDA, 3 Yr. CAGR %	24.67	29.45	22.66	25.54	9.85
EBITA, 3 Yr. CAGR %	30.06	10.27	5.57	8.55	24.62
EBIT, 3 Yr. CAGR %	30.06	13.08	9.23	13.24	24.62
Earnings From Cont. Operations, 3 Yr. CAGR %	39.09	44.51	5.28	0.59	5.63
Net Income, 3 Yr. CAGR %	48.3	52.7	4.63	-0.02	7.43
Normalized Net Income, 3 Yr. CAGR %	42.51	11.68	10.58	13.26	26.86
Diluted EPS Before Extra, 3 Yr. CAGR %	46.69	50.29	3.31	0.24	8.23
Accounts Receivable, 3 Yr. CAGR %	4.73	-8.81	-5.37	-5.27	6.74
Inventory, 3 Yr. CAGR %	-5.56	1.62	10.31	9.35	-9.13
Net Property, Plant and Equip., 3 Yr. CAGR %	11.45	9.74	0.32	-2.61	2.4
Total Assets, 3 Yr. CAGR %	9.15	8.28	8.45	4.84	4.68
Tangible Book Value, 3 Yr. CAGR %	-0.6	18.9	17.38	20.56	14.53
Common Equity, 3 Yr. CAGR %	14.09	20.78	21.26	13.56	8.85
Cash From Operations, 3 Yr. CAGR %	28.36	31.93	-16.56	-0.45	32.66
Capital Expenditures, 3 Yr. CAGR %	11.1	5.19	-8.17	8.22	30.45
Levered Free Cash Flow, 3 Yr. CAGR %	-	2.01	-13.21	-0.5	21.7
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	2.15	-12.99	-0.2	21.08
Dividend Per Share, 3 Yr. CAGR %	14.47	35.72	16.26	10.06	11.87
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	1.2	2.49	3.1	3.6	2.04
Gross Profit, 5 Yr. CAGR %	0.44	3.24	3.74	3.92	3.63
EBITDA, 5 Yr. CAGR %	12.34	18.76	16.26	21.09	16.7
EBITA, 5 Yr. CAGR %	7.64	18.38	19.32	13.72	12.1
EBIT, 5 Yr. CAGR %	7.64	20.51	19.32	15.45	14.42
Earnings From Cont. Operations, 5 Yr. CAGR %	16.93	34.79	16.93	25.97	10.38
Net Income, 5 Yr. CAGR %	16.83	38.92	20.08	30.39	11.87
Normalized Net Income, 5 Yr. CAGR %	11.35	26.83	24.5	15.26	16.07
Diluted EPS Before Extra, 5 Yr. CAGR %	16.06	37.61	19.18	29.73	11.3
Accounts Receivable, 5 Yr. CAGR %	3.1	-5.38	-1.89	-2.73	-1.43
Inventory, 5 Yr. CAGR %	-4.04	3.65	3.97	0.67	-1.5
Net Property, Plant and Equip., 5 Yr. CAGR %	10.76	5.21	7.11	4.56	0.78
Total Assets, 5 Yr. CAGR %	8.03	6.98	7.15	7.37	6.68
Tangible Book Value, 5 Yr. CAGR %	0.14	4.35	6.47	19.25	16.99
Common Equity, 5 Yr. CAGR %	10.55	12.12	13.01	17.4	16.47
Cash From Operations, 5 Yr. CAGR %	22.95	9.78	3.2	33.39	5.63
Capital Expenditures, 5 Yr. CAGR %	14.78	8.89	5.45	8.97	11.66
Levered Free Cash Flow, 5 Yr. CAGR %	28.12	-6.68	4.12	19.93	0.22
Unlevered Free Cash Flow, 5 Yr. CAGR %	26.83	-6.56	4.14	19.66	0.19
Dividend Per Share, 5 Yr. CAGR %	8.45	10.76	12.89	24.57	14.87